- Home
- CPAY vs BNTX Comparison
CPAY vs BNTX Comparison
Compare CPAY & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- BNTX
- Stock Information
- Founded
- CPAY 1986
- BNTX 2008
- Country
- CPAY United States
- BNTX Germany
- Employees
- CPAY N/A
- BNTX N/A
- Industry
- CPAY EDP Services
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPAY Technology
- BNTX Health Care
- Exchange
- CPAY Nasdaq
- BNTX Nasdaq
- Market Cap
- CPAY 24.1B
- BNTX 23.9B
- IPO Year
- CPAY 2010
- BNTX 2019
- Fundamental
- Price
- CPAY $361.58
- BNTX $120.82
- Analyst Decision
- CPAY Buy
- BNTX Strong Buy
- Analyst Count
- CPAY 12
- BNTX 14
- Target Price
- CPAY $379.00
- BNTX $141.60
- AVG Volume (30 Days)
- CPAY 450.9K
- BNTX 1.1M
- Earning Date
- CPAY 02-05-2025
- BNTX 11-04-2024
- Dividend Yield
- CPAY N/A
- BNTX N/A
- EPS Growth
- CPAY 9.84
- BNTX N/A
- EPS
- CPAY 14.01
- BNTX N/A
- Revenue
- CPAY $3,877,478,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- CPAY $8.44
- BNTX N/A
- Revenue Next Year
- CPAY $11.88
- BNTX N/A
- P/E Ratio
- CPAY $25.97
- BNTX N/A
- Revenue Growth
- CPAY 4.68
- BNTX N/A
- 52 Week Low
- CPAY $247.10
- BNTX $76.53
- 52 Week High
- CPAY $385.30
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- CPAY 46.86
- BNTX 59.29
- Support Level
- CPAY $376.60
- BNTX $112.96
- Resistance Level
- CPAY $384.80
- BNTX $125.40
- Average True Range (ATR)
- CPAY 6.75
- BNTX 4.91
- MACD
- CPAY -3.07
- BNTX 1.03
- Stochastic Oscillator
- CPAY 14.00
- BNTX 81.21
About CPAY Corpay Inc.
Corpay Inc is a global S&P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Its suite of modern payment solutions helps its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings), and payables (e.g. paying vendors). This results in its customers saving time and ultimately spending less.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.